- Home
- CCEL vs ACHL Comparison
CCEL vs ACHL Comparison
Compare CCEL & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- ACHL
- Stock Information
- Founded
- CCEL 1989
- ACHL 2016
- Country
- CCEL United States
- ACHL United Kingdom
- Employees
- CCEL N/A
- ACHL N/A
- Industry
- CCEL Managed Health Care
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCEL Health Care
- ACHL Health Care
- Exchange
- CCEL Nasdaq
- ACHL Nasdaq
- Market Cap
- CCEL 50.0M
- ACHL 46.8M
- IPO Year
- CCEL 1997
- ACHL 2021
- Fundamental
- Price
- CCEL $7.40
- ACHL $1.14
- Analyst Decision
- CCEL
- ACHL Buy
- Analyst Count
- CCEL 0
- ACHL 2
- Target Price
- CCEL N/A
- ACHL $4.00
- AVG Volume (30 Days)
- CCEL 13.7K
- ACHL 266.7K
- Earning Date
- CCEL 02-26-2025
- ACHL 11-14-2024
- Dividend Yield
- CCEL 3.38%
- ACHL N/A
- EPS Growth
- CCEL N/A
- ACHL N/A
- EPS
- CCEL N/A
- ACHL N/A
- Revenue
- CCEL $31,838,476.00
- ACHL N/A
- Revenue This Year
- CCEL $3.97
- ACHL N/A
- Revenue Next Year
- CCEL $0.91
- ACHL N/A
- P/E Ratio
- CCEL N/A
- ACHL N/A
- Revenue Growth
- CCEL 1.95
- ACHL N/A
- 52 Week Low
- CCEL $4.47
- ACHL $0.63
- 52 Week High
- CCEL $9.50
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- CCEL 46.30
- ACHL 55.79
- Support Level
- CCEL $6.74
- ACHL $1.12
- Resistance Level
- CCEL $7.50
- ACHL $1.18
- Average True Range (ATR)
- CCEL 0.42
- ACHL 0.05
- MACD
- CCEL -0.02
- ACHL -0.00
- Stochastic Oscillator
- CCEL 56.42
- ACHL 33.33
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.